BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2106441)

  • 1. Reconstitution of H-2 class I expression by gene transfection decreases susceptibility to natural killer cells of an EL4 class I loss variant.
    Sturmhöfel K; Hämmerling GJ
    Eur J Immunol; 1990 Jan; 20(1):171-7. PubMed ID: 2106441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
    Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
    J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
    Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
    J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
    Gorelik E; Jay G; Kwiatkowski B; Herberman RB
    J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
    Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
    Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
    Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
    J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
    Kim M; Duty L; Herberman R; Gorelik E
    Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells.
    Handgretinger R; Kimmig A; Lang P; Daurer B; Kuci S; Bruchelt G; Treuner J; Niethammer D
    Nat Immun Cell Growth Regul; 1989; 8(4):189-96. PubMed ID: 2507905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
    Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
    J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex genes determine natural killer cell tolerance.
    Dorfman JR; Raulet DH
    Eur J Immunol; 1996 Jan; 26(1):151-5. PubMed ID: 8566058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
    Brutkiewicz RR; Klaus SJ; Welsh RM
    Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells.
    Ciccone E; Pende D; Vitale M; Nanni L; Di Donato C; Bottino C; Morelli L; Viale O; Amoroso A; Moretta A
    Eur J Immunol; 1994 Apr; 24(4):1003-6. PubMed ID: 8149950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.
    Versteeg R; Peltenburg LT; Plomp AC; Schrier PI
    J Immunol; 1989 Dec; 143(12):4331-7. PubMed ID: 2512356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.